These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


94 related items for PubMed ID: 3166453

  • 1. Induction of morphological change of human myeloid leukemia and activation of protein kinase C by a novel antibiotic, tautomycin.
    Magae J, Watanabe C, Osada H, Cheng XC, Isono K.
    J Antibiot (Tokyo); 1988 Jul; 41(7):932-7. PubMed ID: 3166453
    [Abstract] [Full Text] [Related]

  • 2. Morphological changes and reorganization of actinfilaments in human myeloid leukemia cells induced by a novel protein phosphatase inhibitor, tautomycin.
    Kurisaki T, Magae J, Nagai K, Hirata A, Kusaka I, Shinji H, Morikawa M, Yoshida T, Isono K, Yamasaki M.
    Cell Struct Funct; 1993 Feb; 18(1):33-9. PubMed ID: 8389250
    [Abstract] [Full Text] [Related]

  • 3. Structure-activity relationship within a series of degradation products of tautomycin.
    Nishiyama U, Ubukata M, Magae J, Kataoka T, Erdödi F, Hartshorne DJ, Isono K, Nagai K, Osada H.
    Biosci Biotechnol Biochem; 1996 Jan; 60(1):103-7. PubMed ID: 8824829
    [Abstract] [Full Text] [Related]

  • 4. Rapid screening method for inhibitors of protein kinase C.
    Osada H, Magae J, Watanabe C, Isono K.
    J Antibiot (Tokyo); 1988 Jul; 41(7):925-31. PubMed ID: 3138226
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Respiratory burst induced by phorbol ester in the presence of tautomycin, a novel inhibitor of protein phosphatases.
    Magae J, Hino A, Isono K, Nagai K.
    J Antibiot (Tokyo); 1992 Feb; 45(2):246-51. PubMed ID: 1556017
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of human promyelocytic leukemia cell (HL60) variants insensitive to phorbol ester tumor promoters.
    Mascioli DW, Estensen RD.
    Cancer Res; 1984 Aug; 44(8):3280-5. PubMed ID: 6331641
    [Abstract] [Full Text] [Related]

  • 12. Induction of differentiation of human myeloid leukemia cells by novel synthetic neurotrophic pyrimidine derivatives.
    Honma Y, Ishii Y, Kasukabe T, Okabe-Kado J, Yamamoto-Yamaguchi Y, Kakegawa T, Awaya A.
    Exp Hematol; 2001 Feb; 29(2):194-201. PubMed ID: 11166458
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Diacylglycerols mimic phorbol diester induction of leukemic cell differentiation.
    Ebeling JG, Vandenbark GR, Kuhn LJ, Ganong BR, Bell RM, Niedel JE.
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):815-9. PubMed ID: 3156372
    [Abstract] [Full Text] [Related]

  • 17. Effect of in vitro differentiation on phorbol diester receptor number in human promyelocytic leukemia (HL-60) cells.
    Lane RW, Sturm RJ, Borzelleca JF, Carchman RA.
    Cancer Res; 1986 Aug; 46(8):3782-8. PubMed ID: 3460690
    [Abstract] [Full Text] [Related]

  • 18. A new antibiotic, tautomycin.
    Cheng XC, Kihara T, Kusakabe H, Magae J, Kobayashi Y, Fang RP, Ni ZF, Shen YC, Ko K, Yamaguchi I.
    J Antibiot (Tokyo); 1987 Jun; 40(6):907-9. PubMed ID: 3610839
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.